-
Mashup Score: 7
Dr Koehi Shitara speaks to ecancer about the expanded efficacy, safety, and subgroup analyses from CheckMate 649. This study investigated nivolumab plus chem
Source: ecancer.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Drug Hits Target in Advanced Biliary Cancer - 3 year(s) ago
Responses in up to a third of patients with FGFR inhibitor infigratinib
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: “This drug was generally well tolerated in patients with advanced #cholangiocarcinomas. Adverse events were generally reversible and manageable and in line with previous observations in this patient population." @AmerGastroAssn #GI21 #AGAConfRep https://t.co/iVQh4fWsra
-
-
Mashup Score: 0New Anti-PD-1 Drug Active in Advanced Colon Cancer - 3 year(s) ago
Almost 40% response rate across a spectrum of gastrointestinal cancers with dostarlimab
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "Patients were enrolled with advanced disease that had progressed on prior therapy and had limited treatment options, a group of patients representing a high unmet need." @AmerGastroAssn #ColonCancer #GI21 #AGAConfRep https://t.co/4nIazEViIh
-
-
Mashup Score: 1Preop RT Flunks Test in Borderline Pancreatic Cancer - 3 year(s) ago
Chemotherapy alone judged efficacious but not chemoradiation
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "Preoperative modified FOLFIRINOX was associated with favorable overall survival relative to historical data in patients with borderline-resectable #pancreatic ductal adenocarcinoma." @AmerGastroAssn #GI21 #AGAConfRep https://t.co/WJ7YJGBEM7
-
-
Mashup Score: 0New Target to Attack in Stomach Cancer - 3 year(s) ago
PFS, OS improved with fibroblast growth factor receptor inhibitor in non-HER2 disease
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: “This is the first study to evaluate targeting the overexpression of FGFR2b in any cancer.” #StomachCancer @AmerGastroAssn #GI21 #AGAConfRep https://t.co/d1gah5G6Rq
-
-
Mashup Score: 0Liquid Biopsy Predicts Colon Cancer Relapse Months Before CT - 3 year(s) ago
Test for ctDNA outperformed existing biomarker, may help guide therapy
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "We saw that patients with circulating tumor DNA (ctDNA) detected immediately after surgery had a very high risk of recurrence." @AmerGastroAssn #GI21 #AGAConfRep #ColonCancer https://t.co/PUjxToZ09T
-
-
Mashup Score: 0Preop Anti-PD-1 No Help in Locally Advanced Rectal Cancer - 3 year(s) ago
Similar rectal score for total neoadjuvant therapy with or without pembrolizumab
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: "Although there was a numerical increase in pathologic complete response, it did not reach statistical significance." @AmerGastroAssn #GI21 #RectalCancer #AGAConfRep https://t.co/SsYSX7cnkf
-
-
Mashup Score: 0Challenges in the approval of therapies for GI cancers - 3 year(s) ago
Lola A. Fashoyin-Aje, MD, MPH, U.S. Food and Drug Administration, outlines challenges associated with the approval of therapies for gastrointestinal…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Challenges in the approval of therapies for GI cancers w/ Lola A. Fashoyin-Aje of @FDAOncology Watch here 👉 https://t.co/tzk7LZwUjI👈 @VJOncology @OncoAlert @ASCO #GI21 #GIsm #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0
Shahid Ahmed, PhD, MD, FRCPC, FACP, Saskatoon Cancer Center, University of Saskatchewan, Saskatoon, Canada, discussing the ongoing CONVERSION trial (NCT03401294),…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: CONVERSION from unresectable to resectable mCRC in real-world patients w/ Shahid Ahmed of @usask Watch here 👉https://t.co/tDSKlUwGrZ👈 @VJOncology @OncoAlert @ASCO #GI21 #GIsm #CRCsm #ColorectalCancer #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0Real-world outcomes of second-line chemotherapy on advanced biliary tract and gallbladder cancers - 3 year(s) ago
Shahid Ahmed, PhD, MD, FRCPC, FACP, Saskatoon Cancer Center, University of Saskatchewan, Saskatoon, Canada, provides an update on the results…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Real-world outcomes of second-line chemotherapy on advanced biliary tract and gallbladder cancers w/ Shahid Ahmed of @usask Watch here 👉https://t.co/PwZ1duUSTq👈 @VJOncology @OncoAlert @ASCO #GI21 #GIsm #HPBCsm #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives
-
RT @KoheiShitara: https://t.co/TiT3N7V3f5 #GI21 @ASCO @OncoAlert